Posted inMarket
Polar Capital Technology Trust Reveals Latest Portfolio Holdings
Explore the latest portfolio holdings disclosed by Polar Capital Technology Trust as they update investors on their technology sector investments.
Posted inMarket
DA Davidson Lowers Broadcom Stock Target Amid Guidance Worries
DA Davidson reduces its price target on Broadcom shares, pointing to potential guidance concerns impacting future performance.
Posted inMarket
UBS Lowers Victorias Secret Price Target to 87 Following Valuation Review
Financial analysts at UBS have adjusted their price target for Victorias Secret down to 87 due to valuation concerns in the retail sector.
Posted inMarket
Cantor Fitzgerald Maintains Neutral Rating on Humana Stock
Cantor Fitzgerald keeps its neutral rating on Humana stock. Read the latest financial analysis and market outlook for healthcare providers.
Posted inMarket
Bernstein Lowers Lululemon Price Target Amid Ongoing Product Challenges
Financial firm Bernstein reduces its price target for Lululemon stock, citing persistent product and inventory hurdles impacting retail performance.
Posted inMarket
Sodexo Stock Price Target Raised by Bernstein Following Strategic Shifts
Bernstein analysts have increased the price target for Sodexo stock to €58.60, highlighting strong operational strategies and growth potential.
Posted inEmerging Market
Bitcoin Holds Strong Above $81000 Driven by Heavy ETF Inflows
Discover the latest cryptocurrency market updates as Bitcoin maintains its position above $81000 amid significant ETF inflows on September 4, 2026.
Posted inMarket
Mizuho Increases UiPath Price Target to 14 Dollars Following Robust Earnings
Mizuho raises UiPath stock price target to 14 dollars following strong financial results and solid business performance in the software sector.
Posted inMarket
Legend Biotech Stock Maintained at Buy by H.C. Wainwright
H.C. Wainwright maintains its buy rating for Legend Biotech, highlighting strong market positioning and ongoing growth potential.
Posted inMarket
Baird Raises DocuSign Stock Price Target Following Strong ARR Growth
Financial firm Baird has increased DocuSign stock price target to $72 following solid annual recurring revenue growth.
